# Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy

> **NCT01445002** · PHASE2 · COMPLETED · sponsor: **Biomay AG** · enrollment: 79 (actual)

## Conditions studied

- Grass Pollen Allergy

## Interventions

- **BIOLOGICAL:** BM32
- **BIOLOGICAL:** BM32
- **BIOLOGICAL:** BM32
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01445002
- **Lead sponsor:** Biomay AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-03
- **Final completion:** 2012-10
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2013-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01445002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01445002, "Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01445002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*